Enzolve Technologies’ highly innovative diagnostic product, the NeoScreenPak, is a suite of tests for screening newborn babies for 7 out of the 11 most commonly screened disorders. These tests will be carried out on a simple single platform that can replace a number of diverse, and often quite complex, technologies currently used world-wide for screening such disorders.

More info…